Premium
Ependymomas factors in clinical and diagnostic staging
Author(s) -
West Charles R.,
Bruce Derek A.,
Duffner Patricia K.
Publication year - 1985
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19851001)56:7+<1812::aid-cncr2820561319>3.0.co;2-1
Subject(s) - medicine , ependymoma , enolase , staging system , disease , pathology , radiology , oncology , cancer , immunohistochemistry
In ependymoma, there is evidence that indicates that age, sex, histologic patterns, functional status, location, duration of symptoms, size, and accessibility to surgical removal influence survival. The role of neuron‐specific enolase and other biologic markers must await the accumulation of further information. Further advances in diagnostic imaging, immunodiagnostics, and intraoperative staging should lead to a better understanding of the disease and pinpoint prognostic factors more precisely. A profile that contains important information is suggested; this should eventually lead to the development of a staging system. Cancer 56: 1812‐1816, 1985.